CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

被引:55
作者
Meisel, Roland [1 ]
机构
[1] Heinrich Heine Univ, Dusseldorf, Germany
关键词
BCL11A;
D O I
10.1056/NEJMc2103481
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 3 条
[1]   CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia [J].
Frangoul, H. ;
Altshuler, D. ;
Cappellini, M. D. ;
Chen, Y-S ;
Domm, J. ;
Eustace, B. K. ;
Foell, J. ;
de la Fuente, J. ;
Grupp, S. ;
Handgretinger, R. ;
Ho, T. W. ;
Kattamis, A. ;
Kernytsky, A. ;
Lekstrom-Himes, J. ;
Li, A. M. ;
Locatelli, F. ;
Mapara, M. Y. ;
de Montalembert, M. ;
Rondelli, D. ;
Sharma, A. ;
Sheth, S. ;
Soni, S. ;
Steinberg, M. H. ;
Wall, D. ;
Yen, A. ;
Corbacioglu, S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (03) :252-260
[2]   Bcl11a is essential for normal lymphoid development [J].
Liu, PT ;
Keller, JR ;
Ortiz, M ;
Tessarollo, L ;
Rachel, RA ;
Nakamura, T ;
Jenkins, NA ;
Copeland, NG .
NATURE IMMUNOLOGY, 2003, 4 (06) :525-532
[3]   Bcl11a Deficiency Leads to Hematopoietic Stem Cell Defects with an Aging-like Phenotype [J].
Luc, Sidinh ;
Huang, Jialiang ;
McEldoon, Jennifer L. ;
Somuncular, Ece ;
Li, Dan ;
Rhodes, Claire ;
Mamoor, Shahan ;
Hou, Serena ;
Xu, Jian ;
Orkin, Stuart H. .
CELL REPORTS, 2016, 16 (12) :3181-3194